It is a crucial result in my view. If the quarter is strong and/or they signal they are well on target for the sales forecast for the year then the share price goes significantly higher. If it is weak then I think we need to revisit the 80c area for a while.
These are big numbers they are looking to do so I don't think they can be taken as a given. That said to date management have always meet or exceed and I think overall have been good at keeping the hyperbole to a minimum. I expect we may get some update on the Screenpoint MOU, I expect some steer on what is the next product off the ramp, maybe something for reconstructive surgery, maybe some insight to where they are with an OEM partner in Japan.